Successful FDA inspection at Yangzhou Aurisco

Release time:2023-08-11

Yangzhou, China, August 11th, 2023 – Aurisco Pharmaceutical announced today that its API and FDF plant in Yangzhou, China has successfully passed a cGMP inspection by the US Food and Drug Administration (USFDA).

See the attachment for details.

Successful FDA inspection at Aurisco’s manufacturing site in Yangzhou, China

版权所有 奥锐特药业股份有限公司 Copyright © 2020 AURISCO.All Rights Reserved 浙ICP备17058154号-1 Legal Notice